NAGE Chromadex Corp: Earnings per share for the last 12 months

Chromadex Corp (NAGE) - corporate logo

Chromadex Corp maintains its leadership in biosynthesis due to exclusive patents for Niagen. The relative EPS YoY TTM growth rate visualizes profit dynamics, where -50.60 serves as the current metric level. However, reliance on a single product, Tru Niagen, creates risks that the company mitigates through licensing. Meanwhile, innovations in cellular energy metabolism are shifting nutraceuticals into the realm of evidence-based medicine.

NAGE niagenbioscience.com: Net earnings per share for the last 12 months in the range 11/23/2025 - 11/17/2026

Financial and market metric breakdowns for Chromadex Corp (NAGE)

- market price and analyst price targets:
Initial company analysis:Chromadex Corp
Product sample of ChromaDex Corporation

This metric measures the annual dynamics of earnings per share, comparing current 10-K and 10-Q reporting data with the market price to identify hidden yield imbalances. By analyzing the rolling year YoY EPS growth chart, an investor can assess how effectively the commercialization of Niagen and the demand for Chromadex Corp (NAGE) biochemical supplements convert into real growth in shareholder value.

Competitor analysis for Chromadex Corp

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato STVN|Net earnings per share (EPS TTM) Teleflex Corp TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical Inc (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Medical ATRC|Earnings per share for the last twelve months STAAR Surgical (STAA)|ZimVie - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CERS (Cerus Corp.)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Orthopedics Inc. MGRM|Sharps Technology, Inc. (STSS) - Earnings per share for the last twelve months|INFU - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months UTMD|Net earnings per one share for the last twelve months korumedical.com KRMD|Net earnings per share for the last 12 months NYXH (Nyxoah S.A.)|Net earnings per share for the last 12 months Microbot Medical, Inc MBOT|Pro-Dex Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ZTEK (Zentek Ltd.)|Elutia Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Milestone Scientific Corp MLSS|NEXGEL, Inc (NXGL) - Earnings per share for the last twelve months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)